New blood test aims to catch ovarian cancer early
NCT ID NCT07491081
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a blood test that looks for tiny particles called extracellular vesicles can help detect ovarian cancer earlier. Researchers will collect blood from 1,500 postmenopausal women aged 50-74 in Queensland, Australia. The main goal is to see if the test is practical in real-world settings, such as how long blood samples can sit before processing. This is not a treatment study—it is about improving future screening methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
blood test for ovarian cancer biomarkers
What this could lead to
If successful, this could help develop a simple blood test to detect ovarian cancer earlier, when treatment is more effective.
What could go wrong
This is an early feasibility study, not a diagnostic trial. It focuses on sample handling, not on whether the test actually detects cancer. Many biomarker tests fail in larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mater Misericordiae Ltd
RECRUITINGBrisbane, Queensland, Australia
Contact
Contact Email: •••••@•••••
-
The University of Queensland
RECRUITINGBrisbane, Queensland, Australia
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••